— Know what they know.
Not Investment Advice
Also trades as: JUPWW (NASDAQ) · $vol 0M

JUPW NASDAQ

Jupiter Wellness, Inc.
1W: +10.1% 1M: -13.8% 3M: +178.7% 1Y: +70.1%
$1.52
Last traded 2023-10-13 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $49.3M mcap · 9M float · 24.99% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$49.3M
52W Range0.305-1.64
Volume1,970,467
Avg Volume2,253,557
Beta0.28
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBrian Scott John
Employees10
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-10-30
1061 East Indiantown Road
Jupiter, FL 33477
US
561 244 7100
About Jupiter Wellness, Inc.

Jupiter Wellness, Inc. specializes in the development of therapeutic and wellness products derived from cannabidiol (CBD). Its clinical development portfolio features several innovative candidates, such as CaniDermRX (JW-100), a unique topical blend of CBD and aspartame aimed at addressing eczema, dermatitis, and actinic keratosis. Also in development are JW-101, a prescription solution designed for burn treatment, and JW-200, an over-the-counter lotion or lip balm formulated to alleviate symptoms associated with cold sores. Beyond its clinical efforts, Jupiter Wellness also manufactures, distributes, and markets a range of consumer goods. These include CBD-enriched sunscreens sold under the CaniSun label, CBD-infused skincare lotions marketed as CaniSkin, and a selection of dermatological remedies for pain and inflammation offered through its CaniDermRX brand. Established in 2018, the company, formerly known as CBD Brands, Inc., maintains its headquarters in Jupiter, Florida.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Gulyas John P-Purchase 3,000 $3.50 2023-12-29
Boon Jarrett Adam 0 — 2023-09-01
Gulyas John P-Purchase 1,666,666 — 2023-08-31
Gulyas John P-Purchase 500 $0.78 2023-08-07
Gulyas John P-Purchase 1,000 $0.78 2023-08-07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms